Multiplikator Forward P/S: BioSig Technologies, Inc. (BSGM)
Biosig Technologies (BSGM) attracts top engineers with unique IT challenges and stock options. The projected market cap-to-revenue ratio on the GURU.Markets service chart visualizes this potential, where 18672.60 captures the current value of the indicator. However, trade barriers are increasing the production costs of systems, and a lack of pricing power due to government procurement pressure is forcing the company to lower the cost of its products.
Ringkesan rincian data analitis BioSig Technologies, Inc (BSGM)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Biosig Technologies|BSGM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Biosig Technologies|BSGM - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku BioSig Technologies, Inc|BSGM - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan BioSig Technologies|Rasio cepet biosig.com
- rincian asil keuangan lan kelipatan valuasi:
BSGM - Penghasilan resik perusahaan|Bathi sing dikarepake Biosig Technologies|BSGM - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi BioSig Technologies, Inc.|BSGM - Pangali PEG|Pangali EV/EBITDA BioSig Technologies, Inc|BSGM - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan BioSig Technologies|BSGM - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan biosig.com|BSGM - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Biosig Technologies
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:BSGM (BioSig Technologies)
The implementation of robotic assembly lines and AI automation within the electrophysiology segment of Biosig Technologies (BSGM) directly impacts future revenue scalability. By analyzing the company's forward P/S ratio, an investor assesses market capitalization relative to expected sales volume, which determines the extent of the premium paid for technological potential and evaluates the sustainability of the current business valuation trend within a portfolio.
Karo sapa Biosig Technologies saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|XAIR (Beyond Air) - Rasio rega marang prakiraan pendapatan|PFSA (Profusa) - Multiplikator Forward P/S|STRATA Skin (SSKN) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan GlucoTrack (GCTK)|NAOV - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Venus Concept Inc. VERO|Rasio kapitalisasi marang dodolan sing dikarepake nuwellis.com (NUWE)|Aethlon Medical, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Asensus Surgical, Inc. ASXC|AVGR: Multiplikator Forward P/S|Prakiraan rega marang pendapatan Cutera Inc CUTR|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan NVRO (Nevro)|Rasio rega marang pendapatan sing dikarepake RSLS|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
